Newsroom

Dieter Jahn
Interview
"Infections and Drugs" is one of four research topics of the Technische Universität Braunschweig. This positions TU Braunschweig as a close partner of the HZI. Their cooperation was the basis of the Systems Biology Centre BRICS that was established jointly in 2011. In an InFact interview, BRICS speaker Dieter Jahn, who is a professor of microbiology, explains how the TU Braunschweig and the HZI may benefit from each other in the long term.
16.04.2018
AESDarstellung des Fingerabdrucks der Genexpression jeder einzelnen Zelle in einer dreidimensionalen Projektion nach bioinformatischer Analyse zur Identifizierung des jeweiligen Zellphänotyps.
News
Stroke and heart attack are the leading cause of death in the Western world. Würzburg scientists have used a special technique to get a clearer picture of the cells involved and their activity. They present their results in the journal Circulation Research.
22.03.2018
Graphisches Modell von Viruspartikeln.
News
Humans are constantly exposed to pathogens like bacteria and viruses. In most cases, the immune system successfully detects and eliminates these invaders. However, the herpesvirus family has adapted brilliantly to the immune system: its members manage to stay in the host’s body for life after infection. A research team at the Helmholtz Centre for Infection Research (HZI) recently discovered that a protein of the carcinogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) commandeers an immune system component for its own benefit. This enables the virus to successfully infect its host. The researchers have published their results in the peer-reviewed journal PLOS Pathogens.
14.03.2018
Bakterien der Art Pseudomonas aeruginosa sind äußerst widerstandfähig und kommen fast überall vor.
News
Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in a densely agglomerated community – a so-called biofilm. Agglomeration in the biofilm protects them from the immune system and even shields them from the effect of antibiotics. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) recently developed a molecule that suppresses the production of biofilms by Pseudomonas. The molecule has another crucial benefit: Due to its small size, it is suitable for oral intake, unlike other drugs of this type. The scientists published their results in Journal of the American Chemical Society. The editors of the journal selected the article as their lead story because of the significance of its findings ("Editor's Choice"). The selection was associated with free-of-charge publication and free access ("Open Access"). The HIPS is a branch of the Helmholtz Centre for Infection Research (HZI), operated in cooperation with the Saarland University and, being a part of the HZI, also is part of the German Center for Infection Research (DZIF).
06.03.2018
Viruspartikel des Grippeerregers H1N1.
News
Time and again – the flu is coming to Germany. The number of cases of the current wave of influenza is still rising. When influenza viruses – the cause of the flu – enter our body, the immune system recognises them as being foreign by means of various receptors and starts a defence programme. Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and of the Otto von Guericke University Magdeburg recently studied the detailed role of a certain receptor in this first line of defence. They discovered that the receptor activates natural killer cells, which use messenger substances to activate other immune cells and then eliminate body cells that are infected by viruses. Deciphering these relationships can reveal new pathways for improvements in the prevention and therapy of influenza infections. The scientists published their results in Frontiers in Immunology.
21.02.2018

HZI in the media

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025
|
Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025
|
Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025
|
PROCESS

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025
|
Bioengineer.org

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025
|
AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025
|
Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025
|
Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025
|
Apotheken Umschau

Register now for the HZI-Newsletter